Robert J. Hill Photo
Email
{{vCardForm.Header}}
{{vCardForm.Body}}
{{vCardForm.CaptchaError}}
{{vCardForm.DisplayMessage}}

Bob handles corporate transactions and provides regulatory counseling relating to health care services, pharmaceuticals and medical devices. He also assists in health care-related litigation, investigations and disputes, and in legislative and regulatory policy issues and related advocacy and drafting.

A core element of Bob’s practice is negotiation of agreements relating to pricing and/or provision of prescription drugs and other health care services. These include:

  • Rebate agreements between pharmaceutical manufacturers and pharmacy benefit managers (PBMs), managed care organizations (MCOs) or other payers, including agreements relating to formulary rebates, market share rebates, outcomes-based rebates (a/k/a value-based rebates), rebates on drugs covered under a medical benefit (including rebates on Part B drugs covered under Medicare Advantage plans), and Medicaid supplemental rebates;

证书

  • University of Michigan Law School, 1987, 法学博士, Cum Laude
  • University of Michigan, 1984, 学士, Economics, with High Distinction and Highest Honors

  • 哥伦比亚特区

  • American Health Lawyers Association

奖项和认可

  • Named a 2017 "Star" (Regulatory) in the LMG Life Science Guide
  • Recognized by Nightingales Healthcare News as one of America's "Outstanding Healthcare Transaction Lawyers" in 2008

Notable Quotes

  • 11 May 2018 "Trump Vows Cheaper Drugs 'Very Soon,' But That's Unlikely" Law360